Screening Rates for Primary Aldosteronism in Resistant Hypertension
Authors:
Top Cited Papers
- 1 March 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 75 (3) , 650-659
Abstract
Resistant hypertension is associated with higher rates of cardiovascular disease, kidney disease, and death than primary hypertension. Although clinical practice guidelines recommend screening for primary aldosteronism among persons with resistant hypertension, rates of screening are unknown. We identified 145 670 persons with hypertension and excluded persons with congestive heart failure or advanced chronic kidney disease. Among this cohort, we studied 4660 persons ages 18 to P P =0.04) and diastolic blood pressure (81.8±13.6 versus 74.4±13.8 mm Hg; P P =0.01), and lower serum potassium concentrations (3.9±0.6 versus 4.1±0.5 mmol/L; P =0.04) than unscreened persons. Screened persons had significantly higher rates of prescription for calcium channel blockers, mixed α/β-adrenergic receptor antagonists, sympatholytics, and vasodilators, and lower rates of prescription for loop, thiazide, and thiazide-type diuretics. The prescription of mineralocorticoid receptor antagonists or other potassium-sparing diuretics was not significantly different between groups ( P =0.20). In conclusion, only 2.1% of eligible persons received a screening test within 2 years of meeting criteria for resistant hypertension. Low rates of screening were not due to the prescription of antihypertensive medications that may potentially interfere with interpretation of the screening test. Efforts to highlight guideline-recommended screening and targeted therapy are warranted.Keywords
This publication has 64 references indexed in Scilit:
- Hyperaldosteronism as a Common Cause of Resistant HypertensionAnnual Review of Medicine, 2013
- Incidence and Prognosis of Resistant Hypertension in Hypertensive PatientsCirculation, 2012
- Underdiagnosis of Hypertension Using Electronic Health RecordsAmerican Journal of Hypertension, 2012
- Factors Affecting the Aldosterone/Renin RatioHormone and Metabolic Research, 2011
- Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008Circulation, 2011
- Prevalence of Resistant Hypertension in the United States, 2003–2008Hypertension, 2011
- Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure MonitoringHypertension, 2011
- Blood Pressure Control by Drug Group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)The Journal of Clinical Hypertension, 2008
- A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive PatientsJACC, 2006
- EFFECTS OF TRIAMTERENE AND AMILORIDE ON URINARY SEDIMENT IN HYPERTENSIVE PATIENTS TAKING HYDROCHLOROTHIAZIDEThe Lancet, 1985